These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35226533)

  • 1. In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome.
    Larson EB; Nelson JC
    Ann Intern Med; 2022 Mar; 175(3):JC35. PubMed ID: 35226533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
    Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
    JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine.
    Yih WK; Kulldorff M; Dashevsky I; Maro JC
    Am J Epidemiol; 2022 Mar; 191(5):957-964. PubMed ID: 35152283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.
    Anderson TC; Leung JW; Harpaz R; Dooling KL
    Hum Vaccin Immunother; 2021 Dec; 17(12):5304-5310. PubMed ID: 34856864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
    Tavares-Da-Silva F; Co MM; Dessart C; Hervé C; López-Fauqued M; Mahaux O; Van Holle L; Stegmann JU
    Vaccine; 2020 Apr; 38(18):3489-3500. PubMed ID: 31818534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of Guillain-Barré Syndrome following recent herpes zoster: a population-based study across Taiwan.
    Kang JH; Sheu JJ; Lin HC
    Clin Infect Dis; 2010 Sep; 51(5):525-30. PubMed ID: 20642353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RF-New Recombinant Vaccine for the Prevention of Herpes Zoster.
    Morgado-Carrasco D; Fustà-Novell X; Giavedoni P
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):67-68. PubMed ID: 31387689
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001.
    Burwen DR; Ball R; Bryan WW; Izurieta HS; La Voie L; Gibbs NA; Kliman R; Braun MM
    Am J Prev Med; 2010 Oct; 39(4):296-304. PubMed ID: 20837279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects & pathomorphology of a polyradiculomyelitic form of herpes zoster].
    STAMMLER A; STRUCK G
    Dtsch Z Nervenheilkd; 1958; 178(3):313-29. PubMed ID: 13597664
    [No Abstract]   [Full Text] [Related]  

  • 13. Varicella-zoster virus: another trigger of Guillain-Barré syndrome?
    Lehmann HC; Hartung HP
    Clin Infect Dis; 2010 Sep; 51(5):531-3. PubMed ID: 20642352
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
    Perez-Vilar S; Hu M; Weintraub E; Arya D; Lufkin B; Myers T; Woo EJ; Lo AC; Chu S; Swarr M; Liao J; Wernecke M; MaCurdy T; Kelman J; Anderson S; Duffy J; Forshee RA
    J Infect Dis; 2021 Feb; 223(3):416-425. PubMed ID: 33137184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization.
    Rome BN; Feldman WB; Fischer MA; Desai RJ; Avorn J
    JAMA Netw Open; 2021 Nov; 4(11):e2135362. PubMed ID: 34797367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes zoster with Guillain-Barré syndrome and orthostatic hypotension; review of motor complications of herpes zoster].
    FRIART J; JEANTY C
    Acta Clin Belg; 1956; 11(4):365-82. PubMed ID: 13372141
    [No Abstract]   [Full Text] [Related]  

  • 19. Guillain-Barré syndrome following hepatitis B vaccination.
    Khamaisi M; Shoenfeld Y; Orbach H
    Clin Exp Rheumatol; 2004; 22(6):767-70. PubMed ID: 15638054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome after reactivation of varicella-zoster virus.
    Roccatagliata L; Uccelli A; Murialdo A
    N Engl J Med; 2001 Jan; 344(1):65-6. PubMed ID: 11187118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.